Page last updated: 2024-08-16

ranitidine and Carcinoma, Non-Small Cell Lung

ranitidine has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bradbury, PA; Hilton, JF; Seymour, L; Shepherd, FA; Tu, D	1
den Bakker, MA; Gelderblom, H; Kloover, JS; van Meerbeeck, JP	1
Diergarten, K; Goes-Schmieder, R; Kober, B; Kolotas, C; Martin, T; Mitrou, PS; Schneider, LV; Vogt, HG; Zamboglou, N	1
Giannikos, L; Gogas, J; Kosmas, C; Polyzos, A; Tsavaris, N	1

Trials

2 trial(s) available for ranitidine and Carcinoma, Non-Small Cell Lung

Article	Year
Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Clemastine; Combined Modality Therapy; Dexamethasone; Drug Administration Schedule; Drug Hypersensitivity; Drug Tolerance; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Radiotherapy Dosage; Ranitidine; Remission Induction; Treatment Outcome	1996
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors. Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4 Topics: Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Nervous System; Dexamethasone; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Premedication; Promethazine; Ranitidine; Safety	1997

Article

Year

Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.

Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16

Topics: Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Clemastine; Combined Modality Therapy; Dexamethasone; Drug Administration Schedule; Drug Hypersensitivity; Drug Tolerance; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Radiotherapy Dosage; Ranitidine; Remission Induction; Treatment Outcome

1996

A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.

Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4

Topics: Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Nervous System; Dexamethasone; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Premedication; Promethazine; Ranitidine; Safety

1997

Other Studies

2 other study(ies) available for ranitidine and Carcinoma, Non-Small Cell Lung

Article	Year
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib. Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:1 Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Ranitidine; Retrospective Studies; Stomach Ulcer; Treatment Outcome	2013
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens. British journal of cancer, 2004, Jan-26, Volume: 90, Issue:2 Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clemastine; Dexamethasone; Drug Hypersensitivity; Fatal Outcome; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Ranitidine; Risk Factors	2004

Article

Year

An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.

Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:1

Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Ranitidine; Retrospective Studies; Stomach Ulcer; Treatment Outcome

2013

Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens.

British journal of cancer, 2004, Jan-26, Volume: 90, Issue:2

Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clemastine; Dexamethasone; Drug Hypersensitivity; Fatal Outcome; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Ranitidine; Risk Factors

2004